# The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin.

> PubMed lists PMID 23813215 in Journal of the American Society of Nephrology : JASN as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-07-11 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-23813215-elamipretide:v1`
- Evidence domain: Literature metadata
- Date in source: 2021-10-21
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-23813215-elamipretide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-23813215-elamipretide-v1.json
- Content SHA-256: `8b2df394b62827b94e575c2c8ea93f367bf5cec41a601e3b5ff210773af5c7fb`

## Claims and source pins

### Headline

The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. ([`pubmed-observation-pmid-23813215-2021-10-21-7ccc75669b0b`](#source-pubmed-observation-pmid-23813215-2021-10-21-7ccc75669b0b))

### Summary

PubMed lists PMID 23813215 in Journal of the American Society of Nephrology : JASN as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-07-11 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23813215-2021-10-21-7ccc75669b0b`](#source-pubmed-observation-pmid-23813215-2021-10-21-7ccc75669b0b))

### Paragraph 1

PubMed lists PMID 23813215 in Journal of the American Society of Nephrology : JASN as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, with publication-date metadata of 2013-07-11 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-23813215-2021-10-21-7ccc75669b0b`](#source-pubmed-observation-pmid-23813215-2021-10-21-7ccc75669b0b))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-23813215-2021-10-21-7ccc75669b0b`](#source-pubmed-observation-pmid-23813215-2021-10-21-7ccc75669b0b))

## Sources

<a id="source-pubmed-observation-pmid-23813215-2021-10-21-7ccc75669b0b"></a>
- **The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin. · retained source version 1:2021-10-21:current:7ccc75669b0b8a5c80bbb2e86accc6419d6a48c6d87b1cc40397c80a9bfca71b** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/23813215/) (`pubmed-observation-pmid-23813215-2021-10-21-7ccc75669b0b`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "The mitochondrial-targeted compound SS-31 re-energizes ischemic mitochondria by interacting with cardiolipin." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-23813215-elamipretide-v1.json SHA-256: 8b2df394b62827b94e575c2c8ea93f367bf5cec41a601e3b5ff210773af5c7fb.